Sanger, Illumina Team Sequences Tasmanian Devil Genome
September 16, 2010
Sanger, Illumina Team Sequences Tasmanian Devil Genome
At a conference in Australia today, researchers from Illumina and the Wellcome Trust Sanger Institute announced that they have sequenced the Tasmanian devil genome, along with tumor genomes representing a contagious cancer decimating wild devil populations.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- New Genomes Serve as Source of Information on Turtle Evolution, Adaptation
April 29, 2013 / GenomeWeb Daily News - WGS IDs Mutational Patterns, Clonal Evolution in Tumors that Could Impact How Cancer is Treated
May 23, 2012 / Clinical Sequencing News - Illumina in Discussions with 100 Potential Clinical Customers for MiSeq, Plans Cancer Diagnostics
April 25, 2012 / Clinical Sequencing News - Sequencing Study Suggests Single Large Rearrangement Events Underlie Some Cancers
January 6, 2011 / GenomeWeb Daily News - Sequencing Survey Finds Customers Happiest with HiSeq 2500
April 16, 2013 / In Sequence